(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.61%) $79.48
(1.24%) $1.956
(0.82%) $2 330.00
(0.34%) $26.84
(1.33%) $967.60
(0.01%) $0.933
(-0.04%) $11.02
(-0.08%) $0.798
(0.27%) $93.51
5.83% $ 2.54
Live Chart Being Loaded With Signals
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 6 642.00 |
Średni wolumen | 9 586.00 |
Kapitalizacja rynkowa | 205.34M |
EPS | $0 ( 2024-03-28 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -25.40 |
ATR14 | $0.0620 (2.57%) |
Innate Pharma S.A. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
ANPC | 0.951 |
EWCZ | 0.947 |
BWEN | 0.935 |
CDZI | 0.931 |
GBLI | 0.93 |
EEFT | 0.924 |
FSV | 0.921 |
AMSC | 0.921 |
CCOI | 0.918 |
FGEN | 0.917 |
10 Najbardziej negatywne korelacje | |
---|---|
SGLB | -0.943 |
LARK | -0.917 |
OP | -0.915 |
HMNF | -0.908 |
RIVN | -0.908 |
SMMF | -0.897 |
MGTA | -0.892 |
UTME | -0.892 |
DBDR | -0.892 |
PIII | -0.887 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Innate Pharma S.A. Finanse
Annual | 2023 |
Przychody: | $51.90M |
Zysk brutto: | $-4.12M (-7.94 %) |
EPS: | $-0.0941 |
FY | 2023 |
Przychody: | $51.90M |
Zysk brutto: | $-4.12M (-7.94 %) |
EPS: | $-0.0941 |
FY | 2022 |
Przychody: | $49.64M |
Zysk brutto: | $-2.02M (-4.08 %) |
EPS: | $-1.240 |
FY | 2021 |
Przychody: | $12.11M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.681 |
Financial Reports:
No articles found.
Innate Pharma S.A.
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; Avdoralimab (IPH5401), a monoclonal antibody blocking C5a binding to C5aR1 that is in Phase II clinicals trials for the treatment of COVID-19, bullous pemphigoid, chronic spontaneous urticaria, and other inflammatory diseases; IPH5201, a blocking antibody that is in Phase 1 clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; and IPH6101, a NKp46-based NK cell engager for the generation and evaluation of up to two bispecific NK cell engagers. Its products in preclinical trials are IPH43, an anti-MICA/B antibody drug conjugate; Anti-Siglec-9, an antibody program; IPH65, a tetraspecific proprietary antibody; IPH25, a checkpoint inhibitor; and IPH62 and IPH64 programs. Innate Pharma S.A. has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. The company was incorporated in 1999 and is headquartered in Marseille, France.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej